Company intelligence / Profile preview

DermacinRx

Sylmar, California, United States
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

DermacinRx is a specialty pharmaceutical brand owned by PureTek Corporation that focuses on the development and commercialization of topical therapies for pain management and dermatology. The company's product portfolio includes a variety of prescription and over-the-counter formulations, such as lidocaine-based patches and gels, corticosteroid creams, and specialized skin repair complexes. DermacinRx is particularly known for its therapeutic kits that combine active pharmaceutical ingredients with supplemental skin care products to enhance patient outcomes and compliance. Based in California, the brand leverages PureTek's manufacturing capabilities to distribute its products through major retail pharmacies and healthcare providers across the United States. As a commercial-stage entity, DermacinRx provides cost-effective alternatives for treating conditions like postherpetic neuralgia, chronic dermatitis, and localized pain.

Therapeutic areas
NeurologyDermatology
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on DermacinRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DermacinRx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call